Aziza E. Abdelrahman

Prognostic impact of EGFR and cytokeratin 5/6 immunohistochemical expression in triple-negative breast cancer

Aziza E. Abdelrahman, Hayam E. Rashed, Mohamed Abdelgawad et al. · Annals of Diagnostic Pathology · 2017 · 54 citations

Breast Oncology, Prognostic Impact, Medicine +8

Fatty acid synthase, Her2/neu, and E2F1 as prognostic markers of progression in non-muscle invasive bladder cancer

Aziza E. Abdelrahman, Hayam E. Rashed, Ehab Elkady et al. · Annals of Diagnostic Pathology · 2019 · 46 citations

Tumor Biology, Urology, Oncology +9

Prognostic value of twist-1, e-cadherin and ezh2 in prostate cancer: an immunohistochemical study

Aziza E. Abdelrahman, Shimaa A Arafa, Ragab A. Ahmed · Turkish Journal of Pathology · 2017 · 30 citations · Full text

Prognostic significance of programmed cell death ligand 1 (pd-l1), cd8+ tumor-infiltrating lymphocytes and p53 in non-small cell lung cancer: an immunohistochemical study

Hayam E. Rashed, Aziza E. Abdelrahman, Mohamed Abdelgawad et al. · Turkish Journal of Pathology · 2017 · 28 citations · Full text

Clinicopathological significance of the immunologic signature (PDL1, FOXP3+ Tregs, TILs) in early stage triple-negative breast cancer treated with neoadjuvant chemotherapy

Aziza E. Abdelrahman, Hayam E. Rashed, MostafaToam et al. · Annals of Diagnostic Pathology · 2020 · 16 citations

Immunologic Signature, Clinicopathological Significance, Breast Oncology +10